Published in Miner Electrolyte Metab on January 01, 1985
Strontium ranelate does not stimulate bone formation in ovariectomized rats. Osteoporos Int (2008) 1.61
Osteoblasts play key roles in the mechanisms of action of strontium ranelate. Br J Pharmacol (2009) 1.30
Age and disease-related changes in the mineral of bone. Calcif Tissue Int (1993) 1.05
The effect of strontium incorporation in hydroxyapatite on osteoblasts in vitro. J Mater Sci Mater Med (2011) 0.92
Addition of Zn to the ternary Mg-Ca-Sr alloys significantly improves their antibacterial property. J Mater Chem B Mater Biol Med (2015) 0.90
In vivo response of strontium and zinc-based ionomeric cement implants in bone. J Mater Sci Mater Med (2002) 0.87
Strontium enhances osseointegration of calcium phosphate cement: a histomorphometric pilot study in ovariectomized rats. J Orthop Surg Res (2013) 0.87
Systemic treatment with strontium ranelate accelerates the filling of a bone defect and improves the material level properties of the healing bone. Biomed Res Int (2014) 0.81
Strontium substituted calcium phosphate biphasic ceramics obtained by a powder precipitation method. J Mater Sci Mater Med (2004) 0.78
Combination of Micronutrients for Bone (COMB) Study: bone density after micronutrient intervention. J Environ Public Health (2012) 0.77
Serum osteoprotegerin concentration with strontium ranelate treatment for postmenopausal osteoporosis: an open, prospective study. Curr Ther Res Clin Exp (2007) 0.75
The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats. Endocrinology (1972) 1.63
An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res (1993) 1.60
Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59
Incorporation and distribution of strontium in bone. Bone (2001) 1.40
The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone (1996) 1.38
Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem (2001) 1.38
Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med (1980) 1.37
The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J Bone Miner Res (1998) 1.31
Relation between hypomineralized periosteocytic lesions and bone mineralization in vitamin D-resistant rickets. Calcif Tissue Int (1983) 1.30
Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Invest (1998) 1.30
Vitamin D metabolites and bone mineralization in man. J Clin Endocrinol Metab (1978) 1.27
Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1(+) cells. J Cell Biochem (2001) 1.24
Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop Relat Res (1983) 1.17
X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. J Clin Endocrinol Metab (1981) 1.15
Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. Metabolism (2004) 1.11
Agenesis of the right pulmonary artery in a young asymptomatic girl. Eur Respir J (1991) 1.11
RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ (2006) 1.10
Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis). J Bone Miner Res (1996) 1.08
Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts. Exp Cell Res (2005) 1.03
Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis. J Bone Miner Res (2001) 1.01
Age at menarche and urbanization in Cameroon: current status and secular trends. Ann Hum Biol (1999) 1.01
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ (1992) 1.00
S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone (2003) 1.00
Osteopontin is associated with bioprosthetic heart valve calcification in humans. C R Acad Sci III (1997) 1.00
Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem (1998) 1.00
Fibroblast growth factor-2 (FGF-2) increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts. J Cell Biochem (2001) 1.00
Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice. Metabolism (2002) 0.99
The prevalence of chondrocalcinosis in the human knee joint. An autopsy survey. J Rheumatol (1988) 0.99
Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome. J Clin Invest (2001) 0.98
Behavior of human osteoblastic cells on stoichiometric hydroxyapatite and type A carbonate apatite: role of surface energy. J Biomed Mater Res (2000) 0.98
The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation. Exp Cell Res (2000) 0.97
Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway. Exp Cell Res (2004) 0.97
Glycol methacrylate as an embedding medium for bone. Stain Technol (1987) 0.96
N- and E-cadherin mediate early human calvaria osteoblast differentiation promoted by bone morphogenetic protein-2. J Cell Physiol (2000) 0.95
Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect. Bone (1996) 0.95
E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis. Cell Death Dis (2013) 0.94
Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. J Clin Invest (1991) 0.94
Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria. J Cell Biochem (1997) 0.93
Vitamin D dependency: replacement therapy with calcitriol? J Pediatr (1981) 0.93
Thrombospondin is synthesized and secreted by human osteoblasts and osteosarcoma cells. A model to study the different effects of thrombospondin in cell adhesion. Eur J Biochem (1989) 0.93
Osteocalcin and bone morphometric parameters in adults without bone disease. Calcif Tissue Int (1988) 0.93
Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene. Hum Mol Genet (1995) 0.92
Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: potential implication in the treatment of age-related bone loss. Histol Histopathol (2004) 0.92
Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using STRO-1 monoclonal antibody. J Bone Miner Res (1999) 0.91
Calcium phosphate metabolism and bone disease in patients with homozygous thalassemia. J Clin Endocrinol Metab (1982) 0.91
Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse. Calcif Tissue Int (1982) 0.91
Activation of phospholipase C-beta1 via Galphaq/11 during calcium mobilization by calcitonin gene-related peptide. J Biol Chem (1998) 0.90
Skeletal unloading induces osteoblast apoptosis and targets alpha5beta1-PI3K-Bcl-2 signaling in rat bone. Exp Cell Res (2006) 0.90
Temporal variation of c-Fos proto-oncogene expression during osteoblast differentiation and osteogenesis in developing rat bone. J Cell Biochem (1995) 0.90
Effects of iron overload on bone remodeling in pigs. Am J Pathol (1984) 0.89
c-fos protooncogene is involved in the mitogenic effect of transforming growth factor-beta in osteoblastic cells. Mol Endocrinol (1995) 0.89
Characterization of endosteal osteoblastic cells isolated from mouse caudal vertebrae. Bone (1988) 0.89
Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats. Endocrinology (1994) 0.89
Decreased bone formation in osteoporotic patients compared with age-matched controls. Calcif Tissue Int (1989) 0.89
Short-term effects of fluoride and strontium on bone formation and resorption in the mouse. Metabolism (1986) 0.88
Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1. Am J Pathol (2001) 0.88
The effect of Prednisolone upon the metabolism and action of 25-hydroxy-and 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A (1974) 0.88
Bone histological heterogeneity in postmenopausal osteoporosis: a sequential histomorphometric study. Bone (1987) 0.87
Production and regulation of interleukin-11 by breast cancer cells. Cancer Lett (1998) 0.87
Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. Cytokine (1997) 0.87
Bone histomorphometric reproducibility in normal patients. Calcif Tissue Int (1981) 0.87
Syndecan-2 is involved in the mitogenic activity and signaling of granulocyte-macrophage colony-stimulating factor in osteoblasts. J Biol Chem (2000) 0.87
Effects of bone morphogenetic protein-2 on human neonatal calvaria cell differentiation. J Cell Biochem (1999) 0.87
An immortalized osteogenic cell line derived from mouse teratocarcinoma is able to mineralize in vivo and in vitro. J Cell Biol (1990) 0.87
Short-term effects of organic silicon on trabecular bone in mature ovariectomized rats. Calcif Tissue Int (1993) 0.87
Effects of low doses of strontium on bone quality and quantity in rats. Bone (1990) 0.87
Involvement of interleukin 1 and tumour necrosis factor alpha as endogenous growth factors in human osteoblastic cells. Cytokine (1995) 0.86
Calcitonin gene-related peptide (CGRP) increases intracellular free Ca2+ concentrations but not cyclic AMP formation in CGRP receptor-positive osteosarcoma cells (OHS-4). Cytokine (1999) 0.86
Bone changes in adult patients with abnormal thyroid function (with special reference to 45Ca kinetics and quantitative histology). Proc R Soc Med (1967) 0.86
Breast cancer cells release factors that induced apoptosis in human bone marrow stromal cells. J Bone Miner Res (2001) 0.86
Genomic insertion of the SV-40 large T oncogene in normal adult human trabecular osteoblastic cells induces cell growth without loss of the differentiated phenotype. Calcif Tissue Int (1999) 0.86
Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance. Cell Death Dis (2013) 0.86
Effects of epidermal growth factor on bone formation and resorption in vivo. Am J Physiol (1990) 0.85
Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse. Endocrinology (1982) 0.85
The effect of differing dietary calcium and phosphorus contents on mineral metabolism and bone histomorphometry in young vitamin D-replete baboons. Calcif Tissue Int (1984) 0.85
Effective doses for strontium ranelate. Osteoporos Int (2008) 0.85
Effects of transforming growth factor type beta on expression of cytoskeletal proteins in endosteal mouse osteoblastic cells. Bone (1990) 0.85
[Cellular aspects of the aging of the articular cartilage. II. Condylar cartilage with fissured surface taken from normal and arthritic knees]. Rev Rhum Mal Osteoartic (1984) 0.85
Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis. Bone (1986) 0.85
Stimulation of cortical bone mineralization and remodeling by phosphate and 1,25-dihydroxyvitamin D in vitamin D-resistant rickets. Metab Bone Dis Relat Res (1981) 0.84
[Cellular aspects of the aging of articular cartilage. I. Condylar cartilage with a normal surface sampled from normal knees]. Rev Rhum Mal Osteoartic (1984) 0.84
Stimulation of trabecular bone formation by insulin-like growth factor I in adult ovariectomized rats. Am J Physiol (1994) 0.84
In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: relationship with cell proliferation. J Clin Endocrinol Metab (1993) 0.84
Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5'-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray. J Bone Miner Res (2001) 0.84